M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer.

Researchers conducted a retrospective study using data from 182 subjects with high-risk recurrent prostate cancers.

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

68 Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177 Lu-PSMA617 in 8 patients with PSA decline ? 98 percent in a prospective phase II study. Any disease ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer after radical prostatectomy, definitive radiotherapy, or salvage radiotherapy.

The centre will leverage fully automated lesion segmentation in PSMA-PET/CT imaging. Malaysia’s Sunway Medical Centre, Sunway ...

New consensus recommendations address implementation of novel treatments and imaging techniques for advanced and ...

Subscribe for FREE This advanced imaging technology plays a critical role in redefining how prostate cancer is staged. PSMA-PET imaging uses tiny amounts of radioactive “tracers,” called radiotracers, ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center, published in JAMA Network Open, shows that nearly half of the ...

These services include specialized options tailored to various cancer types. The PSMA PET CT scan is designed for prostate ...

A new UCLA Health Jonsson Comprehensive Cancer Center-led study has revealed that advanced prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging could reveal ...